Episode · the market · Nov 10, 2:37 PM

NOW: 2026-11-10T19:37Z

WOKE FOR: MARKET (P1 opportunity)

OBSERVATIONS
- 19:36Z setup, P1, salience 86: ROP new session high: closed 474.43 above 473.94 on 10.2× its median minute volume today; opening range 467.49-470.67.
- 19:37Z setup, P1, salience 80: PFE opening-range breakout (first 15 min): closed 29.315 above 29.27 on 4.3× its median minute volume today; opening range 29.1-29.27.
- 19:37Z setup, P1, salience 69: DUOL opening-range breakout (first 15 min): closed 157.98 above 156.83 on 2.5× its median minute volume today; opening range 155.15-156.83.
- 19:37Z setup, P1, salience 65: FTV opening-range breakout (first 15 min): closed 67.295 above 67.19 on 2.4× its median minute volume today; opening range 66.62-67.19.

YOUR BOOK (the paper account: your decisions trade it; started with $10,000)
cash $3829.51 · equity $10209.65 (+2.1%) · today -0.09% · 8 stocks, 0 options positions
- MPC: 1 shares at 383.85, now 386.3 (0.56%), stop 312.05, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 148.9% (skipping the last month), 25.9% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- PSX: 2 shares at 248.78, now 249.13 (0.13%), stop 212.58, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:01 AM ET. Thesis: Long-term leader: 12-month return 107.2% (skipping the last month), 21.7% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- PTC: 7 shares at 195.33, now 196.23 (0.49%), stop 190.75, target none, TREND CORE (rules-managed: its stop trails and a close below the 50-day average sells it; sell it yourself only on news that breaks the trend), multi_day horizon, opened 10:01 AM ET. Thesis: Trend core: 16.8% above a 50-day average 12.9% over the 200-day; 6-month 33% at 1.17% daily ATR (strength 28.2); 100% of its 52-week high Invalidation: The trailing stop, or a close below the 50-day average.
- S: 107 shares at 23.57, now 23.375 (-0.81%), stop 22.66, target 25, multi_day horizon, opened 9:46 AM ET. Thesis: Strongest setup: price above SMA20/50/200, positive 5d return, heavy volume breakout. Opening range low 22.66 provides tight stop. Reward 6% vs risk 4% (R:R > 1.2). Invalidation: Price closes below 22.66.
- SPY: 1 shares at 747.67, now 748.435 (0.10%), stop none, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term book: SPY at 15% of equity, held while its weekly close stays above its 200-day average: last week closed at 735.29, 0.67% vs its 200-day average 730.38. Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- U: 2 shares at 52.97, now 49.74 (-6.06%), stop 47.67, target none, TREND CORE (rules-managed: its stop trails and a close below the 50-day average sells it; sell it yourself only on news that breaks the trend), multi_day horizon, opened 10:01 AM ET. Thesis: Trend core: 21.2% above a 50-day average 34% over the 200-day; 6-month 82.8% at 5.23% daily ATR (strength 15.84); 97% of its 52-week high Invalidation: The trailing stop, or a close below the 50-day average.
- USO: 3 shares at 143.74, now 141.22 (-1.71%), stop 115.75, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 107.8% (skipping the last month), 17.8% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- VLO: 1 shares at 352.24, now 348.4 (-1.09%), stop 300.25, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 160.8% (skipping the last month), 19.4% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).

LIMITS (enforced by code)
- Market: the regular session. New buys: allowed.
- Your envelope: 2/8 entries in 24 h, 0/3 in the last hour, 1/4 open; one action per ticker per 30 min; no re-entry for 6 h after a stop-out or 2 h after an exit.
- Sizing is code's: a buy risks 1% of equity at its stop (×0.75 at conviction 6, up to ×1.25 at 10), up to 25% of equity per position ($2552.41). A closer stop means more shares; leave allocation_pct null.
- Risk checks: 3/8 positions; conviction ≥ 6/10 (no intraday buys in the closing window); price ≥ $5; stop 0.4-10% below the price (default 2.5%); reward:risk ≥ 1.2; no rebuy within 15 min of a sale; $3625.32 deployable cash.
- Options: open premium $0 of the 25% of equity cap ($2552); at most 4% of equity per position; 0/6 positions; conviction ≥ 7; long calls and puts, call and put debit spreads; buy |delta| 0.25-0.7, 7-45 days to expiration; contracts only from an option_menu result in this episode; exits default to -60% / +150% of the position's value, and code closes positions before expiration.
- Intraday stock positions are closed by code in the last minutes of the session; overnight and multi-day ones stay. Stops and targets rest at the broker as bracket or OCO orders, and once a position is up by its stop distance code trails its stop at that distance behind the price.

MARKET
- SPY 748.435 (-0.57%), QQQ 671.785 (-1.03%), IWM 280.05, DIA 521.5, VIXY 18.42, TLT 80.84

SUBJECT ROP
- 474.325; technicals: use the tools
- news: nothing in our feeds about it in the last 24 h

SUBJECT PFE
- 29.315; technicals: use the tools
- news in our feeds, last 24 h, most severe first:
<untrusted source="wire">
64abdcaf9cf9 [Nov 9, 5:02 PM ET | T2 zacks.com | fda | sev 64] Can Moderna's First Cancer Therapy Win FDA Approval in 2027? (https://www.zacks.com/stock/news/3026694/can-moderna-s-first-cancer-therapy-win-fda-approval-in-2027?cid=CS-ZC-FT-analyst_blog|quick_take-3026694)
> machine summary of the article: Moderna and Merck plan to submit an FDA application for intismeran by year-end 2026, potentially leading to approval in 2027. Phase III results showed the therapy reduced recurrence or death risk by 42% compared to Keytruda alone. However, manufacturing capacity and patient turnaround times remain undisclosed challenges. Management stated it is too early to provide pricing guidance.
</untrusted>

SUBJECT DUOL
- 157.98; technicals: use the tools
- news in our feeds, last 24 h, most severe first:
<untrusted source="wire">
9f37d72e0e7f [Nov 10, 9:55 AM ET | T1 anomaly | price shock | sev 79 | +1.9% since] DUOL -1.08% in 1 min (z -5.73 after removing SPY's move)
f0e62ddc3a83 [Nov 10, 10:20 AM ET | T1 anomaly | price shock | sev 78 | +0.8% since] DUOL +1.16% in 1 min (z 5.66 after removing SPY's move)
266859f46b73 [Nov 10, 2:36 PM ET | T1 anomaly | price shock | sev 65 | +0.0% since] DUOL +0.95% in 1 min (z 4.74 after removing SPY's move)
</untrusted>

SUBJECT FTV
- 67.295; technicals: use the tools
- news in our feeds, last 24 h, most severe first:
<untrusted source="wire">
167bed9dff95 [Nov 10, 9:41 AM ET | T1 anomaly | price shock | sev 88 | +0.9% since] FTV -0.… [cut: 9,675 characters in all]

{
  "decisions": [],
  "watches": [],
  "cancel_watches": [],
  "notes": [],
  "reply": "The session is closed (19:37Z ET). No new entries are allowed in the closing window or after hours. All observed setups (ROP, PFE, DUOL, FTV) lack confirmed catalysts or have unconfirmed news, and the market is already past the close. I am holding all 8 positions; no exits are triggered by the rules or news."
}